ModerateCardiovascularChronic heart failure with reduced ejection fractionuk-plab-1
A 70-year-old man with known heart failure with reduced ejection fraction (HFrEF) is on Ramipril and Bisoprolol at target doses but remains NYHA class II–III. His renal function and potassium are normal. What is the most appropriate additional disease-modifying drug?